Tempest Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -78.4% | -55.3% | -38.6% |
| FY2022 | -197.2% | -125.4% | -77.5% |
| FY2023 | -110.2% | -89.3% | -57.1% |
| FY2024 | -218.8% | -218.8% | -100.9% |
| FY2025 | -393.9% | -393.9% | -155.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -78.4% | -55.3% | -38.6% |
| FY2022 | -197.2% | -125.4% | -77.5% |
| FY2023 | -110.2% | -89.3% | -57.1% |
| FY2024 | -218.8% | -218.8% | -100.9% |
| FY2025 | -393.9% | -393.9% | -155.1% |